UPDATED Dec 08, 2023
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
2268WuXi XDC Cayman | HK$28.80 | -10.6% | n/a | HK$33.9b | HK$28.00 | PE132.6x | E45.2% | n/a | ||
2096Simcere Pharmaceutical Group | HK$6.77 | -7.6% | -28.7% | HK$17.7b | HK$10.80 | PE5.2x | E-24.9% | 2.6% | ||
950Lee's Pharmaceutical Holdings | HK$1.37 | -9.9% | -26.3% | HK$806.7m | HK$1.00 | PE20.7x | S13.5% | 1.2% | ||
2142HBM Holdings | HK$1.41 | -9.0% | -31.9% | HK$1.0b | n/a | PS2.4x | n/a | n/a | ||
1477Ocumension Therapeutics | HK$6.83 | -0.6% | -33.0% | HK$4.7b | HK$12.88 | PS20.8x | E46.4% | n/a | ||
1652Fusen Pharmaceutical | HK$1.39 | -2.8% | 26.4% | HK$1.0b | n/a | PS1.4x | n/a | 0% | ||
2480Beijing Luzhu Biotechnology | HK$30.00 | -10.4% | n/a | HK$6.1b | HK$38.19 | PB4.8x | E-10.7% | n/a | ||
2171CARsgen Therapeutics Holdings | HK$9.02 | -2.3% | -43.6% | HK$5.2b | HK$14.53 | PB2.2x | E11.5% | n/a | ||
1177Sino Biopharmaceutical | HK$3.37 | -9.7% | -25.8% | HK$62.0b | HK$5.64 | PE30.2x | E17.7% | 2.4% | ||
1558YiChang HEC ChangJiang Pharmaceutical | HK$9.45 | 1.0% | 28.2% | HK$8.3b | HK$11.00 | PE6.7x | E32.0% | 0% | ||
1877Shanghai Junshi Biosciences | HK$20.60 | -13.1% | -39.1% | HK$41.5b | HK$33.53 | PS15.2x | E31.4% | n/a | ||
1801Innovent Biologics | HK$39.75 | -9.7% | 23.3% | HK$64.3b | HK$56.14 | PS11.7x | E61.1% | n/a | ||
6622Zhaoke Ophthalmology | HK$4.07 | -3.1% | 23.3% | HK$2.2b | HK$6.62 | PS179.5x | E49.1% | n/a | ||
1061Essex Bio-Technology | HK$2.18 | -16.2% | -46.8% | HK$1.2b | HK$5.12 | PE4.8x | E24.9% | 3.2% | ||
575Regent Pacific Group | HK$0.70 | 0% | -55.7% | HK$159.9m | n/a | PB1.8x | n/a | n/a | ||
3692Hansoh Pharmaceutical Group | HK$14.40 | -9.3% | -6.7% | HK$85.3b | HK$16.32 | PE30.4x | E11.3% | 1.0% | ||
9939Kintor Pharmaceutical | HK$1.85 | 1.1% | -87.1% | HK$827.9m | HK$13.34 | PB0.6x | E2.4% | n/a | ||
1521Frontage Holdings | HK$2.01 | -7.8% | -16.3% | HK$4.1b | HK$2.29 | PE30.1x | E25.6% | n/a | ||
2126JW (Cayman) Therapeutics | HK$2.94 | -7.3% | -42.7% | HK$1.2b | HK$3.49 | PS6.5x | E28.1% | n/a | ||
1167Jacobio Pharmaceuticals Group | HK$3.68 | 1.1% | -39.8% | HK$2.9b | HK$7.06 | PS32.9x | E-27.9% | n/a | ||
12443D Medicines | HK$8.50 | -4.0% | n/a | HK$2.2b | n/a | PS2.8x | n/a | n/a | ||
1952Everest Medicines | HK$19.62 | -2.1% | 37.8% | HK$6.3b | HK$26.68 | PS278.3x | E-23.4% | n/a | ||
6996Antengene | HK$2.17 | 3.3% | -54.6% | HK$1.5b | HK$4.38 | PS7.5x | E12.5% | n/a | ||
2005SSY Group | HK$4.76 | -2.7% | 17.5% | HK$14.1b | HK$5.99 | PE11.9x | E20.4% | 3.2% |